0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      ESPRIT: a European study of the prevention of reocclusion after initial thrombolysis with duteplase in acute myocardial infarction.

      1 , ,
      European heart journal
      Oxford University Press (OUP)

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The goal of thrombolytic treatment in acute myocardial infarction is reperfusion of the infarct-related coronary artery. Duteplase is a double-chain recombinant tissue-type plasminogen activator. Its efficacy and safety were evaluated in patients with acute myocardial infarction treated within 4 h of onset of chest pain in this multicentre, open, non-controlled trial.

          Related collections

          Author and article information

          Journal
          Eur. Heart J.
          European heart journal
          Oxford University Press (OUP)
          0195-668X
          0195-668X
          Oct 1996
          : 17
          : 10
          Affiliations
          [1 ] Glaxo Wellcome Research and Development, Beckenham, Kent, U.K.
          Article
          10.1093/oxfordjournals.eurheartj.a014716
          8909909
          4fd35156-c2f0-4412-bdf5-92a3d46ff29f
          History

          Comments

          Comment on this article